guest ::
DAVIAD
The development of a novel therapeutic vaccine for the selective treatment of the autoimmune disorder, Graves’ disease.
| Coordinator | GLAXOSMITHKLINE BIOLOGICALS SA ; APITOPE INTERNATIONAL NV ; QUINTILES BENEFIT FRANCE INC ; KWS BIOTEST LIMITED |
| Grant period | 2013-12-01 - 2018-06-30 |
| Funding body | European Union |
| Call number | FP7-HEALTH-2013-INNOVATION-1 |
| Grant number | 602779 |
| Identifier | G:(EU-Grant)602779 |
Recent Publications
There are no publications
Record created 2014-01-12, last modified 2023-03-01